Speaker Profile
PhD, Co-Founder & CEO, Huma.AI
Biography
Dr. Feng spent over 20 years in precision medicine. Dr. Feng came from NovartisOncology Business Unit where she established international partnerships for their targeted cancer therapeutics programs. She joined Novartis through its acquisition of Genoptix. Dr. Feng built the BioPharma division at Genoptix, where she grew the business from zero to $45M in five years by forging alliances with pharmaceutical companies and providing companion diagnostics development for targeted cancer therapies. The division was instrumental in Genoptix acquisition by Novartis for $500M.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair:
Gad Getz, Broad Institute
- PMWC 2024 Luminary Award
Luminary Honoree: Heidi Rehm, MGH and Broad Institute
- Opening Talk: The Power of Data by Track Chair Gaddy Getz, Broad Institute
- Challenges of Remote Data Harmonization and Querying (PANEL)
Chair: Heidi Rhem, MGH and Broad Institute
- Chris Lunt, All of Us
- Simona Carini, UCSF
- Josh Peterson, Emerge/Vanderbilt University Medical Center
- Nara Sobreira, Johns Hopkins/GeneMatcher - Promoting Global Collaboration for Data Sharing: Overcoming Organizational and Sectoral Barriers (PANEL)
Chair: Gad Getz, Broad Institute
- Peter Goodhand, GA4GH
- Valentina Di Francesco, NHGRI
- Melanie Courtot, ICGC-ARGO
- Erica Galvez, Manifest MedEx - Keynote: Machine Learning for Therapeutic Discovery
- Daphne Koller, insitro
- Exploring the Power of AI and Data Sciences in Drug Discovery (PANEL)
Chair: Michelle Chen, Insilico Medicine
- Kim Branson, GSK
- Laszlo Radvanyi, Ontario Institute for Cancer Research
- Martin Stumpe, Tempus
- Sun-Gou Ji, BridgeBio
- Angela Oliveira Pisco, Insitro - Foundation Models to Advance Precision Medicine (PANEL)
Chair: Nigam Shah, Stanford
- Aashima Gupta, Google
- Rod Tarrago, AWS
- Lana Feng, Huma.ai - PMWC Showcase
- Janusz Dutkowski, Data4Cure
